More Antibiotic Treatment Options for TB and Shigellosis

Drug Discovery Platform For Tuberculosis And Shigellosis

Tags: National University of Singapore, Singapore, Healthcare & Lifesciences

---

This platform identifies crucial host targets for TB and shigellosis, enabling host-directed therapies. It uses gene-editing tools for drug discovery, countering antibiotic resistance. The technology could expand the drug repertoire against TB, offering alternative or adjunct therapies. It also allows for the repurposing of existing drugs, potentially accelerating treatment innovation and supporting global health goals.

---

IP Type or Form Factor: Discovery & Research; Platform

TRL: 3 - proof of concept with needs validated

Industry or Tech Area: Pharmaceutical Engineering; Diagnostics & Screening

---

More Antibiotic Treatment Options for TB and Shigellosis

---

Find out more with contact information